STRATEGY MODE

Defensive

Low / Medium

Prioritize risk control, stronger evidence and lower exposure to unstable setups.

6–18 months

Holding

Monthly

Rebalance

TOP SELECTION RANKED

ADBTAdvasa Holdings, Inc.

Model Fit Score79%

Defensive ranked 10 newly public companies by deterministic fit. ADBT leads at 79% fit, with 3 names clearing the high-conviction threshold.

Ranked

newly public

Avg fit

68%

across universe

Strong matches

fit ≥ 70%

Top score

intelligence core

Sectors

covered

Every Core ranked by rule-based fit against this strategy (SEC + market signals). Review a Core before you act · no capital moves here, allocations are suggestions until you deploy through your Strategy Vault.

Your constraints

Capital

Max position · 20%

Cash reserve · 30%

Max positions · 6

Risk tolerance

You pick the strategy and control the limits. Allocations are deterministic and fit-weighted, never set by the model.

Ranked recommendations · 10

Portfolio Composition100% Capital Accounted

ADBT16%MI16%TBCV14%SNSC13%TP12%USDG Reserve30%

#	Company	Score	Strategy fit	Allocation
1	ADBTAdvasa Holdings, Inc. Day 59 public · Services-Prepackaged Software	77	x 79	16% $1,600
2	MINFT Ltd Day 47 public · Finance Services	72	x 77	16% $1,569
3	CRISCURIS INC Day 58 public · Biological Products, (No Diagnostic Substances)	77	x 73
4	TBCVThunder Bridge Capital Partners V, Ltd. Day 58 public · Blank Checks	71	x 69	14% $1,402
5	BLSMBlossomHill Therapeutics, Inc. Day 64 public · Pharmaceutical Preparations	75	x 67
6	LTGOLatigo Biotherapeutics, Inc. Day 64 public · Pharmaceutical Preparations	76	x 67
7	BRVEBraveheart Bio, Inc. Day 65 public · Pharmaceutical Preparations	74	x 66
8	SNSCSunScout Holding Ltd Day 58 public · Semiconductors & Related Devices	57	x 62	13% $1,260
9	TPTicketplus Ltd. Day 64 public · Services-Miscellaneous Amusement & Recreation	62	x 58	12% $1,168
10	ADRXADARx Pharmaceuticals, Inc. Day 12 public · Pharmaceutical Preparations	65	x 56
	Cash reserve · USDG (Phase 3)			30% $3,000